Literature DB >> 3056354

Heterogeneity in macular corneal dystrophy.

D P Edward1, B Y Yue, J Sugar, E J Thonar, N SunderRaj, E L Stock, M O Tso.   

Abstract

Macular corneal dystrophy is an autosomal recessive disorder in which abnormal deposits in the corneal stroma have been identified. We examined the corneal buttons of 12 patients, who had clinical features of macular dystrophy, by histochemical staining, transmission electron microscopy, and immunohistochemical techniques. All corneas exhibited positive staining with Muller Mowry's colloidal iron. Using monoclonal antibodies 1/20/5-D-4, J-10, J-19, and J-36 that recognize specific sites on the sulfated keratan sulfate molecule, we stained corneal sections by an avidin-biotin-peroxidase complex method and identified two groups of macular corneal dystrophy. One group consisting of four corneas reacted positively with all four antibodies, and the other group consisting of eight corneas did not react with any of the antibodies used. These results confirmed those recently presented by Yang et al that there may be subgroups of macular dystrophy that can be identified by immunohistochemical methods. Also, serum levels of sulfated keratan sulfate were determined in seven patients. One patient who displayed a normal level of serum keratan sulfate had positive corneal immunoreactivity. Of the six patients who lacked serum keratan sulfate, four showed negative and two had positive corneal immunostaining, suggesting at least three subgroups in the disease. An attempt was made to correlate the clinical features, histochemical-staining characteristics, and ultrastructural morphology with the immunoreactivity to keratan sulfate antibodies, but no correlations could be made.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056354     DOI: 10.1001/archopht.1988.01060140747049

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Multipotent stem cells in human corneal stroma.

Authors:  Yiqin Du; Martha L Funderburgh; Mary M Mann; Nirmala SundarRaj; James L Funderburgh
Journal:  Stem Cells       Date:  2005-07-28       Impact factor: 6.277

2.  Proteoglycans contain a 4.6 A repeat in muscular dystrophy corneas: x-ray diffraction evidence.

Authors:  A J Quantock; G K Klintworth; D J Schanzlin; M S Capel; M E Lenz; E J Thonar
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

3.  Secretion and organization of a cornea-like tissue in vitro by stem cells from human corneal stroma.

Authors:  Yiqin Du; Nirmala Sundarraj; Martha L Funderburgh; Stephen A Harvey; David E Birk; James L Funderburgh
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

4.  Macular corneal dystrophy: mutational spectrum in German patients, novel mutations and therapeutic options.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Wolfram Heinritz; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-24       Impact factor: 3.117

5.  Differential immunogold localisation of sulphated and unsulphated keratan sulphate proteoglycans in normal and macular dystrophy cornea using sulphation motif-specific antibodies.

Authors:  Robert D Young; Tomoya O Akama; Petra Liskova; Neil D Ebenezer; Bruce Allan; Briedgeen Kerr; Bruce Caterson; Michiko N Fukuda; Andrew J Quantock
Journal:  Histochem Cell Biol       Date:  2006-08-30       Impact factor: 4.304

6.  Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6.

Authors:  Xiuhong Dang; Qingguo Zhu; Li Wang; Hong Su; Hui Lin; Nan Zhou; Ting Liang; Zheng Wang; Shangzhi Huang; Qiushi Ren; Yanhua Qi
Journal:  Mol Vis       Date:  2009-04-06       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.